This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sekido, Y. Articles by Minna, J. D. Search for Related Content PubMed PubMed Citation Articles by Sekido, Y. Articles by Minna, J. D.

Molecular Analysis of the HuD Gene Encoding a Paraneoplastic Encephalomyelitis Antigen in Human Lung Cancer Cell Lines¹

Departments of Internal Medicine and Pharmacology, Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas 75235 [Y. S., S. A. B., D. P. C., J. D. M.], and Navy Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20889 [B. E. J.]

Small cell lung cancer (SCLC) is known to express the HuD protein, the neuronal antigen homologous to Drosophila Elav and Sxl genes involved in neuronal and sex development. HuD is the target of an immune response including high titered antibodies causing paraneoplastic encephalomyelitis and sensory neuropathy. Because the p53 recessive oncogene is mutated and anti-p53 antibodies frequently occur in cancer patients, we wondered if the development of anti-HuD antibodies signaled the presence of HuD mutations in lung cancer. The HuD gene was mapped to chromosome region 1p using a human-mouse hybrid cell panel. We confirmed that 26 of 46 cancer (43 lung cancer and 3 mesothelioma) cell lines expressed HuD mRNA and that this expression, as well as protein expression by Western blot, correlated strongly with the SCLC neuroendocrine phenotype. Southern blot and single-strand conformation polymorphism analyses showed that HuD was not mutated in 78 lung cancers, including patients with the severe paraneoplastic syndrome. Northern blot analysis showed that lung cancer cell lines expressed two major mRNAs (4.3 and 4.0 kilobases) of HuD. We found the three previously described alternative spliced mRNA forms (HuDpro, HuD, and HuDmex). In addition, we also found HuD mRNA had an alternative splicing form in its 5'-coding region. This alternative splice introduced 87 base pairs of sequence and a termination codon resulting in a predicted small, truncated protein (11 amino acids) reminiscent of the male-specific truncated protein in the Sex-lethal (Sxl) gene of Drosophila. However, mRNAs encoding both full-length and truncated proteins were expressed in all SCLCs. These results show that the HuD gene is not mutated in lung cancer, including tumors from patients producing anti-HuD antibodies, but HuD expression is an independent marker or determinant of the neuroendocrine differentiation seen in SCLC.

¹ This work was supported by the Julie Gould Foundation (S. A. B.), the G. Harold and Leila Y. Mathers Charitable Foundation, and National Cancer Institute Grant P 20 CA58220-01.

² To whom requests for reprints should be addressed, at Simmons Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75235-8590.

Received 4/21/94. Accepted 7/12/94.

This article has been cited by other articles:

				E. Bjorling, C. Lindskog, P. Oksvold, J. Linne, C. Kampf, S. Hober, M. Uhlen, and F. Ponten A Web-based Tool for in Silico Biomarker Discovery Based on Tissue-specific Protein Profiles in Normal and Cancer Tissues Mol. Cell. Proteomics, May 1, 2008; 7(5): 825 - 844. [Abstract] [Full Text] [PDF]

				G. Ito, M. Uchiyama, M. Kondo, S. Mori, N. Usami, O. Maeda, T. Kawabe, Y. Hasegawa, K. Shimokata, and Y. Sekido Kruppel-Like Factor 6 Is Frequently Down-Regulated and Induces Apoptosis in Non-Small Cell Lung Cancer Cells Cancer Res., June 1, 2004; 64(11): 3838 - 3843. [Abstract] [Full Text] [PDF]

				R. B. Darnell and J. B. Posner Paraneoplastic Syndromes Involving the Nervous System N. Engl. J. Med., October 16, 2003; 349(16): 1543 - 1554. [Full Text] [PDF]

				N. L. Bernasconi, T. A. M. Wormhoudt, and I. A. Laird-Offringa Post-Transcriptional Deregulation of myc Genes in Lung Cancer Cell Lines Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 560 - 565. [Abstract] [Full Text]

				A. Ohwada, I. Nagaoka, F. Takahashi, S. Tominaga, and Y. Fukuchi DNA Vaccination against HuD Antigen Elicits Antitumor Activity in a Small-Cell Lung Cancer Murine Model Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 37 - 43. [Abstract] [Full Text]